safety-surg
recon-patient-safety
patient-safety

OPUS breast implants are clinically shown to have low complication rates1

A robust 10-year clinical study – the largest breast implant study of its kind – revealed unrivaled safety and clinical results

1,788 patients enrolled

|

37 plastic surgery sites

|

evaluated for 10 years

primary augmentation complication rates1

12.9%

Capsular Contracture
III/IV

8.7%

Rupture
(MRI Cohort)

24.2%

Reoperation

Key Complications Primary Augmentation (smooth and textured devices) Through 10 years,
by Patient KM Risk Estimates

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Sientra 10-Yr
N=1,116

  • 2,230
  • 398
  • 12.9%
  • 8.7%
  • 24.2%

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Mentor 10-Yr
N=552

  • 1,102
  • 220
  • 12.1%
  • 24.2%
  • 25.5%

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Allergan 10-Yr
N=455

  • 908
  • 158
  • 18.9%
  • 9.3%
  • 36.1%

primary reconstruction complication rates1

15.8%

Capsular Contracture
III/IV

16.5%

Rupture
(MRI Cohort)

48.2%

Reoperation

Key Complications Primary Reconstruction Cohort Through 10 years,
by Patient KM Risk Estimates

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Sientra 10-Yr
N=225

  • 412
  • 48
  • 15.8%
  • 16.5%
  • 48.2%

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Mentor 10-Yr
N=251

  • 410
  • 134
  • 20.5%
  • 32.7%
  • 49.0%

 
 

  • Number of Implants
  • MRI Cohort Patients
  • Capsular Contracture III/IV
  • Rupture (MRI Cohort)
  • Reoperation

Allergan 10-Yr
N=98

  • 127
  • 51
  • 24.6%
  • 35.4%
  • 71.5%
timing

board-certified

plastic surgeon exclusively
a commitment to excellence

Sientra is the ONLY major silicone gel breast implant manufacturer to sell exclusively to board-certified plastic surgeons. We believe this results in safer and more beautiful patient outcomes. Several key opinion leaders have recently expressed the importance of BCPS exclusivity:

quote

Only one major implant manufacturer exclusively sells to board-certified plastic surgeons. The data shows they have superior long-term rupture and capsular contracture rates. This is not a coincidence.
- Troy A. Pittman, MD | Washington, DC

Only one major implant manufacturer exclusively sells to board-certified plastic surgeons. The data shows they have superior long-term rupture and capsular contracture rates. This is not a coincidence.
- Troy A. Pittman, MD | Washington, DC

Only one major implant manufacturer exclusively sells to board-certified plastic surgeons. The data shows they have superior long-term rupture and capsular contracture rates. This is not a coincidence.
- Troy A. Pittman, MD | Washington, DC

...
connect with us
scroll-top
Scroll to top